In collaboration with leading experts in fermentation at the Centre for Process Innovation (CPI, Newcastle, UK), Algipharma has secured combined funding (2.700.000 NOK) from the UK’s Technology Strategy Board and Innovation Norway for pilot scale studies for production of its promising new alginate oligomer drug candidate. The funding also provides for continued support from SINTEF consolidating their key expertise in laboratory scale fermentation of alginates.
For further information, please contact:
Arne Dessen, Chairman of Board; email@example.com
Philip D. Rye R&D Director; firstname.lastname@example.org